Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,962 | 206 | 93.1% |
| Education | $441.88 | 5 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $995.64 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $619.37 | 25 | $0 (2024) |
| Lilly USA, LLC | $536.63 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $532.36 | 30 | $0 (2024) |
| ABBVIE INC. | $480.49 | 20 | $0 (2024) |
| UCB, Inc. | $345.88 | 10 | $0 (2024) |
| Amgen Inc. | $305.91 | 8 | $0 (2024) |
| Incyte Corporation | $283.64 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $267.51 | 10 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $265.84 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,667 | 118 | GENZYME CORPORATION ($742.28) |
| 2023 | $735.91 | 25 | E.R. Squibb & Sons, L.L.C. ($143.21) |
| 2022 | $1,132 | 34 | Lilly USA, LLC ($267.98) |
| 2021 | $869.25 | 34 | Ortho Dermatologics, a division of Bausch Health US, LLC ($201.13) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $46.09 | General |
| Category: WOUND CARE | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $40.68 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Immunology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $36.66 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.65 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $43.58 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $37.59 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $41.51 | General |
| Category: Immunology | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,304 | 1,829 | $423,445 | $66,061 |
| 2022 | 14 | 1,416 | 2,164 | $447,027 | $84,319 |
| 2021 | 14 | 1,146 | 2,085 | $380,170 | $67,849 |
| 2020 | 14 | 1,075 | 1,798 | $341,017 | $51,704 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 308 | 344 | $83,790 | $16,400 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 212 | $72,201 | $14,509 | 20.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 114 | 120 | $46,866 | $7,576 | 16.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 209 | 241 | $67,609 | $7,418 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $32,999 | $5,494 | 16.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 95 | 97 | $34,235 | $5,269 | 15.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $19,121 | $2,492 | 13.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 143 | 505 | $39,790 | $2,016 | 5.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 40 | $5,482 | $1,253 | 22.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 15 | $6,614 | $1,164 | 17.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 25 | 25 | $5,587 | $1,008 | 18.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 22 | 25 | $4,619 | $811.42 | 17.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 18 | $3,690 | $606.47 | 16.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 53 | $842.83 | $44.60 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 266 | 356 | $67,113 | $18,228 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 169 | $46,171 | $12,996 | 28.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 153 | 182 | $62,168 | $12,422 | 20.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 166 | 166 | $48,311 | $8,819 | 18.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 208 | 269 | $81,676 | $8,341 | 10.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $32,350 | $8,333 | 25.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 115 | 126 | $36,141 | $7,127 | 19.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 135 | 584 | $43,146 | $2,479 | 5.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 21 | 23 | $8,299 | $1,764 | 21.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 34 | $5,016 | $1,108 | 22.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 25 | 34 | $5,260 | $1,086 | 20.7% |
About Amy Cavanagh, MSN, FNP
Amy Cavanagh, MSN, FNP is a Nurse Practitioner healthcare provider based in Smithfield, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902856776.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Cavanagh, MSN, FNP has received a total of $6,404 in payments from pharmaceutical and medical device companies, with $3,667 received in 2024. These payments were reported across 211 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,962).
As a Medicare-enrolled provider, Cavanagh has provided services to 4,941 Medicare beneficiaries, totaling 7,876 services with total Medicare billing of $269,933. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Family
- Location Smithfield, NC
- Active Since 05/11/2006
- Last Updated 05/27/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1902856776
Products in Payments
- DUPIXENT (Biological) $1,660
- TREMFYA (Drug) $853.73
- Bimzelx (Biological) $345.88
- OPZELURA (Drug) $283.64
- RINVOQ (Biological) $282.42
- Otezla (Drug) $282.00
- Sotyktu (Drug) $232.18
- ILUMYA (Biological) $224.49
- EUCRISA (Drug) $211.44
- COSENTYX (Drug) $201.15
- DUOBRII (Drug) $185.58
- Zoryve (Drug) $179.91
- SKYRIZI (Biological) $159.34
- TALTZ (Drug) $138.19
- VTAMA (Drug) $74.50
- COSENTYX (Biological) $66.36
- SILIQ (Drug) $64.71
- CIBINQO (Drug) $50.22
- AFFINITY (Medical Supply) $46.09
- OLUMIANT (Drug) $41.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Smithfield
Sheryl Morrisey, Arnp-C, ARNP-C
Nurse Practitioner — Payments: $2,909
Phyllis Merritt-James, Np, NP
Nurse Practitioner — Payments: $1,487
Mrs. Katrina Griffin, Np, NP
Nurse Practitioner — Payments: $1,131
Markiesha Edgerton, Np, NP
Nurse Practitioner — Payments: $822.53
Mrs. Maureen Adams, Fnp-Bc, Np-C, FNP-BC, NP-C
Nurse Practitioner — Payments: $584.90
Angela Demetrius, Msn, Aprn, Fnp-Bc, MSN, APRN, FNP-BC
Nurse Practitioner — Payments: $94.01